Company intelligence / Profile preview

Huons

Seongnam-si, Gyeonggi-do/Sujeong-gu, South Korea
Ownership
Public · 243070
Employees
~900
Development stage
Phase 3
01

Overview

Huons has a strong commercial presence in Korea and internationally with injectable drugs (notably local anesthetics), eye drops including preservative-free formulations with leading market share in Korea ("Kynex"), medical devices, dietary supplements/probiotics. Recent clinical progress includes Phase I IND approval for HUC1‑394 targeting dry eye disease. The company continues to expand its biopharmaceutical pipeline through acquisitions like PanGen to develop biosimilars/human-derived enzymes such as hyaluronidase.

Therapeutic areas
OphthalmologyNeurologyWomen's Health
Modalities
Small moleculesbiologicshyaluronic acid productshuman-derived enzymes such as hyaluronidase
Industry
Biotech
02

Drug pipeline

17 assets

honokiol

3

16 more assets in the full pipeline.

Request access →
03

Partnerships

Alcon Co. strategic alliance for ophthalmic products/Kynex seriesGENCURIX MOU for COVID‑19 diagnosticsAju University tech transfer contract

Beyond the preview

Go deeper on Huons.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huons.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call